Goal, the parent company of Facebook, has again delayed the return of its employees in the United States to their offices. After several postponements, this time he has set the next 28th March like the day your workers will return to your facilities. Of course, in order to do so, they will have to have the booster dose of the COVID-19 vaccine injected. The company is going to ask its employees for proof of this.
As they have stated from Meta, the delay in returning to their offices will give workers more flexibility in terms of how they organize their work amid the effects of the pandemic. Until this announcement, the company had set January 31 as the day to return to its facilities for its US workers and for the complete reopening of its offices. But it has not been possible.
If Meta employees want to continue working remotely after March 28, they will have to request a postponement from the company before mid-March. Of course, the postponements granted will only be between three and five months. But if they do not want to return to the office, according to the Wall Street Journal, they also have the option of requesting telecommuting permanently. In any case, they also have until mid-March to decide which way to go.
Janelle Gale, Vice President of Human Resources at Meta, stated that the company is focused on «in ensuring that our employees continue to have options to choose from where they work, given the current COVID-19 landscape. We understand that ongoing uncertainty makes this a difficult time to make decisions about where to work from, so we’re giving you more time to choose what works best for you.«.
The expansion of the Omicron variant of COVID-19 has forced several of the Silicon Valley tech companies and companies to delay your plans back at the office again. They have done so, and also indefinitely, companies such as Manzana or Google. This has not only happened in the case of Meta, but the company is one of the first within large companies to tell its employees that they will be asked for proof of having the booster dose of the vaccine against COVID-19 to return in person to the office.
